General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Special Voting Preferred Stock
Common
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total Stockholder's Equity
Noncontrolling Interest in Consolidated Subsidiary
Total
Balance at Jun. 30, 2019 $ 1,059 $ 46,299,233 $ (27,582,558) $ 18,717,734 $ 18,717,734
Balance (in Shares) at Jun. 30, 2019 10,589,746            
Common stock issued upon warrant exercise $ 37 4,247,028 4,247,065 4,247,065
Common stock issued upon warrant exercise (in Shares) 369,311            
Common stock issued in business combinations $ 230 20,081,236 20,081,466 20,081,466
Common stock issued in business combinations (in Shares) 2,299,650            
Non-controlling interest in acquired subsidiary     5,554,011 5,554,011
Stock-based compensation     1,253,234 1,253,234 1,253,234
Forfeitures of restricted shares $ (5) 5
Forfeitures of restricted shares (in Shares)   (54,901)            
Change in fair value of Convertible Notes 63,000 63,000 63,000
Warrant Adjustment 21,738 21,738 21,738
Foreign currency translation adjustments              
Unrealized (loss) gains on convertible notes               63,000
Net loss (13,572,311) (13,572,311) (849,759) (14,422,070)
Balance at Jun. 30, 2020 $ 1,321 71,902,474 63,000 (40,969,044) 30,997,751 4,704,252 35,702,003
Balance (in Shares) at Jun. 30, 2020 13,203,806            
Issuance of common stock $ 500 11,031,880 11,032,380 11,032,380
Issuance of common stock (in Shares)   5,000,000            
Special voting preferred stock issued in business combination $ 25,203,490 25,203,490 25,203,490
Special voting preferred stock issued in business combination (in Shares) 3,294,574            
Conversion of Exchangeable Shares to common stock $ (4,798,271) $ 63 4,798,208
Conversion of Exchangeable Shares to common stock (in Shares) (627,225) 627,225            
Settlement of convertible debt $ 11 359,989 360,000 360,000
Settlement of convertible debt (in Shares) 112,867            
Non-controlling interest in acquired subsidiary $ 80 4,695,357 4,695,437 (4,695,437)
Non-controlling interest in acquired subsidiary (in Shares) 800,000            
Stock-based compensation 1,298,540 1,298,540 1,298,540
Restricted stock vesting $ 15 (15)
Restricted stock vesting (in Shares) 157,350            
Foreign currency translation adjustments (21,497) (21,497) (21,497)
Unrealized (loss) gains on convertible notes (133,000) (133,000) (133,000)
Net loss (16,210,481) (16,210,481) (8,815) (16,219,296)
Adoption of ASC 606 Adjustment 185,825 185,825 185,825
Balance at Dec. 31, 2020 $ 20,405,219 $ 1,990 94,086,433 (91,497) (57,179,525) 57,222,620   57,222,620
Balance (in Shares) at Dec. 31, 2020 2,667,349 19,901,248            
Conversion of Exchangeable Shares to common stock $ (7,803,475) $ 102 7,803,373    
Conversion of Exchangeable Shares to common stock (in Shares) (1,020,062) 1,020,062            
Settlement of convertible debt $ 208 8,467,292     8,467,500
Settlement of convertible debt (in Shares) 2,080,140            
Shares withheld for withholding taxes $ (5) (333,842)     (333,847)
Shares withheld for withholding taxes (in Shares) (48,948)            
Stock-based compensation 503,379     503,379
Restricted stock vesting $ 1 (1)    
Restricted stock vesting (in Shares) 13,978            
Forfeitures of restricted shares (in Shares)   (668)            
Liabilities settled with shares $ 10 377,315     377,325
Liabilities settled with shares (in Shares) 101,705            
Foreign currency translation adjustments (230)     (230)
Unrealized (loss) gains on convertible notes (13,000)     (13,000)
Net loss (6,457,703)     (6,457,703)
Balance at Mar. 31, 2021 $ 12,601,744 $ 2,306 110,903,949 (104,727) (63,637,228)     59,766,044
Balance (in Shares) at Mar. 31, 2021 1,647,287 23,067,517            
Balance at Dec. 31, 2020 $ 20,405,219 $ 1,990 94,086,433 (91,497) (57,179,525) 57,222,620   $ 57,222,620
Balance (in Shares) at Dec. 31, 2020 2,667,349 19,901,248            
Issuance of common stock (in Shares)               556,388
Conversion of Exchangeable Shares to common stock $ (18,039,181) $ 237 18,038,944
Conversion of Exchangeable Shares to common stock (in Shares) (2,358,063) 2,358,063            
Settlement of convertible debt $ 309 11,610,277 11,610,586 $ 11,610,586
Settlement of convertible debt (in Shares) 3,094,129           12,484,395
Shares withheld for withholding taxes $ (12) (520,383) (520,395) $ (520,395)
Shares withheld for withholding taxes (in Shares) (121,786)            
Shares issued in connection with Viridian Acquisition $ 103 6,187,897 6,188,000 6,188,000
Shares issued in connection with Viridian Acquisition (in Shares) 1,031,000            
Shares issued in connection with Asset Purchase $ 8 299,992 300,000 300,000
Shares issued in connection with Asset Purchase (in Shares) 83,333            
Shares issued in connection with 365 Cannabis Acquisition $ 357 11,995,704 11,996,061 11,996,061
Shares issued in connection with 365 Cannabis Acquisition (in Shares) 3,571,429            
Stock-based compensation   2,070,358 2,070,358 2,070,358
Shares issued in connection with the ATM program $ 56 1,828,063 1,828,119 1,828,119
Shares issued in connection with the ATM program (in Shares) 556,388            
Restricted stock vesting $ 42 (42)
Restricted stock vesting (in Shares) 427,711           32,394
Forfeitures of restricted shares (in Shares) (1,336)            
Liabilities settled with shares $ 10 430,015 430,025 $ 430,025
Liabilities settled with shares (in Shares) 101,705            
Foreign currency translation adjustments 53,020 53,020 53,020
Unrealized (loss) gains on convertible notes 100,000 100,000 100,000
Net loss (31,328,711) (31,328,711) (31,328,711)
Balance at Dec. 31, 2021 $ 2,366,038 $ 3,100 146,027,258 61,523 (88,508,236) $ 59,949,683 59,949,683
Balance (in Shares) at Dec. 31, 2021 309,286 31,001,884            
Conversion of Exchangeable Shares to common stock $ (18,620) 18,620    
Conversion of Exchangeable Shares to common stock (in Shares) (2,434) 2,434            
Settlement of convertible debt $ 340 3,299,660     3,300,000
Settlement of convertible debt (in Shares) 3,396,842            
Shares withheld for withholding taxes (5,615)     (5,615)
Shares withheld for withholding taxes (in Shares) (4,421)            
Shares returned in connection with 365 Cannabis acquisition $ (28) (939,972)     (940,000)
Shares returned in connection with 365 Cannabis acquisition (in Shares) (279,762)            
Stock-based compensation 316,855     316,855
Restricted stock vesting $ 4 (4)    
Restricted stock vesting (in Shares) 43,479            
Liabilities settled with shares $ 1 45,065     45,066
Liabilities settled with shares (in Shares) 14,632            
Foreign currency translation adjustments (33,800)     (33,800)
Unrealized (loss) gains on convertible notes 101,000     101,000
Net loss (21,952,893)     (21,952,893)
Balance at Mar. 31, 2022 $ 2,347,418 $ 3,417 $ 148,761,867 $ 128,723 $ (110,461,129)     $ 40,780,296
Balance (in Shares) at Mar. 31, 2022 306,852 34,175,088